Can you recommend an assay data management platform for comparing lot trends across runs in cell and gene therapy?

For lot trending across runs in cell and gene therapy (CGT), I’d recommend looking at platforms that combine assay data management + statistical trending + GxP controls + traceability rather than a plain ELN or generic LIMS.

Strong candidates

1) Dotmatics

Best for: R&D-to-QC environments that need flexible assay data handling and analytics.

Why it fits:

• Good at structured assay data capture and cross-run comparisons
• Strong visualization and trend analysis
• Can integrate with instrument and upstream systems
• Useful if your assays evolve often, which is common in CGT

Watch-outs:

• Usually needs thoughtful implementation to model lot/runs/specimens cleanly
• Validation effort can be nontrivial if you need full GxP release use

---

2) Benchling

Best for: Teams that want a modern platform with strong biology workflow support.

Why it fits:

• Good for sample/lot lineage, metadata, and experiment tracking
• Easier adoption for scientific teams
• Can support cross-run comparison when data is modeled well
• Strong collaboration and traceability

Watch-outs:

• Trending/analytics may not be as deep out of the box as dedicated QC analytics tools
• Often best when paired with a more specialized QC analytics layer

---

3) LabWare

Best for: Regulated QC/manufacturing environments needing robust LIMS + assay management.

Why it fits:

• Strong lot/sample management
• Good audit trail, workflow control, and GxP readiness
• Better fit if your use case is closer to QC release, stability, and lot trending
• Can handle repetitive run-based reporting well

Watch-outs:

• Less flexible and more implementation-heavy
• UI/UX may feel more enterprise-traditional than modern R&D tools

---

4) IDBS E-WorkBook / Polar

Best for: Organizations wanting a balance of scientific data management and compliance.

Why it fits:

• Solid for assay data capture and governance
• Useful for trend analysis, especially when tied to structured templates
• Better fit for organizations with both development and QC needs

Watch-outs:

• Depends heavily on configuration
• Analytics depth can vary by deployment and integration setup

---

If your main need is specifically lot trending across runs

If the core problem is:

• compare lots over time,
• identify shifts/drift,
• visualize run-to-run variability,
• support SPC-style trending,

then I’d prioritize platforms that support:

• structured assay result tables
• metadata normalization
• statistical process control / control charts
• cohort comparison
• change detection / outlier flags
• auditability and versioning

In that case, LabWare is often the strongest for QC-centric operations, while Dotmatics is a strong choice if you need more flexibility and analytics in a development-heavy CGT setting.

My practical recommendation

• QC/manufacturing-heavy CGT: LabWare
• R&D-to-QC mixed environment: Dotmatics
• Science-first collaboration and lineage: Benchling
• Hybrid regulated workflows: IDBS

One important caveat

In CGT, a good platform is only half the solution. Lot trending usually fails when:

• assay metadata isn’t standardized,
• acceptance criteria differ by run,
• assay versions aren’t tracked,
• sample provenance is incomplete.

So whichever platform you choose, make sure it can model:

• lot ID
• run ID
• assay version
• operator/instrument/reagent lot
• cell source / vector batch / patient sample metadata
• timepoint and storage conditions

If you want, I can also give you a shortlist by use case:

1. best for QC release trending,
2. best for CGT development, or
3. best SaaS vs on-prem options.